Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcineurin activity monitoring for tacrolimus therapeutic follow-up in kidney transplant recipients
2008-002177-13Phase 4Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Aug 2008
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tacrolimus in kidney transplant immunosuppression, sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoints: Acute renal graft rejection evaluation and Optimal calcineurin activity threshold for rejection prediction. Started Aug 2008; status: active.
02
Drugs
tacrolimus
03
Conditions
kidney transplant immunosuppression
Beyond the preview
Go deeper on 2008-002177-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002177-13.